These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 31039772)

  • 1. "Then I went to a hospital abroad": acknowledging implications of stakeholders' differing risk understandings related to use of complementary and alternative medicine in European health care contexts.
    Salamonsen A; Wiesener S
    BMC Complement Altern Med; 2019 Apr; 19(1):93. PubMed ID: 31039772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which risk understandings can be derived from the current disharmonized regulation of complementary and alternative medicine in Europe?
    Wiesener S; Salamonsen A; Fønnebø V
    BMC Complement Altern Med; 2018 Jan; 18(1):11. PubMed ID: 29321023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of complementary and alternative medicine in patients with cancer or multiple sclerosis: possible public health implications.
    Salamonsen A
    Eur J Public Health; 2016 Apr; 26(2):225-9. PubMed ID: 26450914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.
    Salamonsen A
    Forsch Komplementmed; 2015; 22(1):24-9. PubMed ID: 25824401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epistemological challenges in contemporary Western healthcare systems exemplified by people's widespread use of complementary and alternative medicine.
    Salamonsen A; Ahlzén R
    Health (London); 2018 Jul; 22(4):356-371. PubMed ID: 28401813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholders' perspectives on the regulation and integration of complementary and alternative medicine products in Lebanon: a qualitative study.
    Alameddine M; Naja F; Abdel-Salam S; Maalouf S; Matta C
    BMC Complement Altern Med; 2011 Aug; 11():71. PubMed ID: 21871124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legal status and regulation of complementary and alternative medicine in Europe.
    Wiesener S; Falkenberg T; Hegyi G; Hök J; Roberti di Sarsina P; Fønnebø V
    Forsch Komplementmed; 2012; 19 Suppl 2():29-36. PubMed ID: 23883942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards a pan-European definition of complementary and alternative medicine--a realistic ambition?
    Falkenberg T; Lewith G; Roberti di Sarsina P; von Ammon K; Santos-Rey K; Hök J; Frei-Erb M; Vas J; Saller R; Uehleke B
    Forsch Komplementmed; 2012; 19 Suppl 2():6-8. PubMed ID: 23883939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory environment for complementary and alternative medicine in Georgia-a health policy analysis.
    Nadareishvili I; Pkhakadze G; Japiashvili N; Lunze K
    Int J Health Plann Manage; 2021 Jul; 36(4):1038-1051. PubMed ID: 33735447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of Integrative Medicine Practices and Policies in NATO Participant Countries.
    Hegyi G; Petri RP; Roberti di Sarsina P; Niemtzow RC
    Med Acupunct; 2015 Oct; 27(5):318-327. PubMed ID: 26543517
    [No Abstract]   [Full Text] [Related]  

  • 12. What attitudes and needs do citizens in Europe have in relation to complementary and alternative medicine?
    Nissen N; Schunder-Tatzber S; Weidenhammer W; Johannessen H
    Forsch Komplementmed; 2012; 19 Suppl 2():9-17. PubMed ID: 23883940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concluding comments: maximizing good patient care and minimizing potential liability when considering complementary and alternative medicine.
    Gilmour J; Harrison C; Vohra S
    Pediatrics; 2011 Nov; 128 Suppl 4():S206-12. PubMed ID: 22045865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research.
    Fischer FH; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    BMC Complement Altern Med; 2014 Feb; 14():46. PubMed ID: 24499316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doctor-patient communication and cancer patients' choice of alternative therapies as supplement or alternative to conventional care.
    Salamonsen A
    Scand J Caring Sci; 2013 Mar; 27(1):70-6. PubMed ID: 22583118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging complementary and alternative medicine policy initiatives and the need for dialogue.
    Knox KE; Fønnebø V; Falkenberg T
    J Altern Complement Med; 2009 Sep; 15(9):959-62. PubMed ID: 19697994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EU FP7 project 'CAMbrella' to build European research network for complementary and alternative medicine.
    Weidenhammer W; Lewith G; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; von Ammon K; Baumhöfener F; Brinkhaus B
    Forsch Komplementmed; 2011; 18(2):69-76. PubMed ID: 21576975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical review of complementary and alternative medicine use among people with arthritis: a focus upon prevalence, cost, user profiles, motivation, decision-making, perceived benefits and communication.
    Yang L; Sibbritt D; Adams J
    Rheumatol Int; 2017 Mar; 37(3):337-351. PubMed ID: 27889825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient-Centeredness, and Practice Context.
    Tilburt J; Yost KJ; Lenz HJ; Zúñiga ML; O'Byrne T; Branda ME; Leppin AL; Kimball B; Fernandez C; Jatoi A; Barwise A; Kumbamu A; Montori V; Koenig BA; Geller G; Larson S; Roter DL
    Oncologist; 2019 Nov; 24(11):e1180-e1189. PubMed ID: 31101701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
    Singh H; Maskarinec G; Shumay DM
    Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.